German Pharmacies Fear Advance Of Supermarkets

25 September 1997

Germany's pharmacy monopoly is once again under the spotlight as theEconomics Ministry reviews the current drug pricing regulations.

Around 1.07 billion packs of drugs prescribed by doctors were sold exclusively through pharmacies last year, and even for the packs not specifically restricted to pharmacy distribution, there has been little or no competition up to the present.

Nevertheless, the so-called "problem" of over-the-counter medicines is said to be causing increasing concern in pharmacies. Last year, supermarkets, consumer markets and drug stores sold about 100 million packs of vitamins, laxatives, tonics and similar products, while pharmacies sold about 50 million units of OTC items. OTC sales accounted for only 1.5% of the nationwide turnover of some 45 billion Deutschemarks ($25.12 billion) by Germany's 21,000 pharmacies.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight